Windlas Biotech Ltd.(IN:WINDLAS)
₹999.40+22.90 (+2.35%)
IN:WINDLAS
Windlas Biotech Ltd. Revenue
₹999.40
At close:+22.90 (+2.35%)
Want to see IN:WINDLAS full AI Analyst Report?
Windlas Biotech Ltd. (WINDLAS) Revenue
2 Followers
Windlas Biotech Ltd. Revenue
Windlas Biotech Ltd. had a revenue of 2.48B in the quarter ending Jun 30, 2026, with 4.03%. This bring the company's revenue in the last twelve months to 9.42B, Increased 4.20%. In the fiscal year ending Mar 31, 2026, Windlas Biotech Ltd. had annual revenue of 9.04B with 18.98% growth.
- Revenue (ttm)
- 9.42B
- Revenue Growth
- 18.48%
- P/S Ratio
- 2.23
- Revenue/Employee
- INR 6,527,718
- Employees
- 1,385
- Market Cap
- INR 20.15B
Revenue Chart
Windlas Biotech Ltd. Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 9.04B | 1.44B | 18.98% |
| Mar 31, 2025 | 7.60B | 1.31B | 20.83% |
| Mar 31, 2024 | 6.29B | 1.18B | 23.17% |
| Mar 31, 2023 | 5.11B | 472.08M | 10.19% |
| Mar 31, 2022 | 4.63B | 366.61M | 8.59% |
| Mar 31, 2021 | 4.27B | 982.82M | 29.92% |
| Mar 31, 2020 | 3.28B | 231.70M | 7.59% |
| Mar 31, 2019 | 3.05B | -467.30M | -13.28% |
| Mar 31, 2018 | 3.52B | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company | Revenue |
|---|---|
| IN:WINDLAS | 9.42B |
| IN:INDOCO | 18.59B |
| IN:INDSWFTLAB | 6.65B |
| IN:MOREPENLAB | 19.51B |
| IN:SYNCOMF | 4.98B |
| IN:VENUSREM | 8.11B |